1. Home
  2. FLGT

FLGT

Fulgent Genetics Inc.

Logo Fulgent Genetics Inc.

Health Care

Medical Specialities

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Founded: 2011 Country:
United States
United States
Employees: N/A City: EL MONTE
Market Cap: 635.4M IPO Year: 2016
Target Price: $30.00 AVG Volume (30 days): 215.2K
Analyst Decision: Hold Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.63 EPS Growth: N/A
52 Week Low/High: $20.66 - $44.09 Next Earning Date: 05-03-2024
Revenue: $289,213,000 Revenue Growth: -53.27%
Revenue Growth (this year): 1.48% Revenue Growth (next year): 15.93%

Share on Social Networks: